388 related articles for article (PubMed ID: 18229605)
1. [Advances and related issues in the use of in vitro methods to predict metabolic clearance rate of new drugs].
Zhang Q; Wang GJ
Yao Xue Xue Bao; 2007 Oct; 42(10):1023-8. PubMed ID: 18229605
[TBL] [Abstract][Full Text] [Related]
2. Use of intrinsic clearance for prediction of human hepatic clearance.
Chao P; Uss AS; Cheng KC
Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):189-98. PubMed ID: 20073997
[TBL] [Abstract][Full Text] [Related]
3. The prediction of human clearance from hepatic microsomal metabolism data.
Obach RS
Curr Opin Drug Discov Devel; 2001 Jan; 4(1):36-44. PubMed ID: 11727321
[TBL] [Abstract][Full Text] [Related]
4. Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance.
Fagerholm U
J Pharm Pharmacol; 2007 Oct; 59(10):1427-31. PubMed ID: 17910819
[TBL] [Abstract][Full Text] [Related]
5. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.
Fagerholm U
J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173
[TBL] [Abstract][Full Text] [Related]
6. In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises.
Miners JO; Knights KM; Houston JB; Mackenzie PI
Biochem Pharmacol; 2006 May; 71(11):1531-9. PubMed ID: 16455060
[TBL] [Abstract][Full Text] [Related]
7. Physiologically based approaches towards the prediction of pharmacokinetics: in vitro-in vivo extrapolation.
De Buck SS; Mackie CE
Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):865-78. PubMed ID: 18028030
[TBL] [Abstract][Full Text] [Related]
8. Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches.
Hosea NA; Collard WT; Cole S; Maurer TS; Fang RX; Jones H; Kakar SM; Nakai Y; Smith BJ; Webster R; Beaumont K
J Clin Pharmacol; 2009 May; 49(5):513-33. PubMed ID: 19299532
[TBL] [Abstract][Full Text] [Related]
9. The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data.
Obach RS; Baxter JG; Liston TE; Silber BM; Jones BC; MacIntyre F; Rance DJ; Wastall P
J Pharmacol Exp Ther; 1997 Oct; 283(1):46-58. PubMed ID: 9336307
[TBL] [Abstract][Full Text] [Related]
10. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.
Riley RJ; McGinnity DF; Austin RP
Drug Metab Dispos; 2005 Sep; 33(9):1304-11. PubMed ID: 15932954
[TBL] [Abstract][Full Text] [Related]
11. Prediction of human pharmacokinetics - renal metabolic and excretion clearance.
Fagerholm U
J Pharm Pharmacol; 2007 Nov; 59(11):1463-71. PubMed ID: 17976256
[TBL] [Abstract][Full Text] [Related]
12. First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Li H; Sun J; Sui X; Liu J; Yan Z; Liu X; Sun Y; He Z
Eur J Med Chem; 2009 Apr; 44(4):1600-6. PubMed ID: 18768239
[TBL] [Abstract][Full Text] [Related]
13. Prediction of human pharmacokinetics--gut-wall metabolism.
Fagerholm U
J Pharm Pharmacol; 2007 Oct; 59(10):1335-43. PubMed ID: 17910807
[TBL] [Abstract][Full Text] [Related]
14. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes.
Obach RS
Drug Metab Dispos; 1999 Nov; 27(11):1350-9. PubMed ID: 10534321
[TBL] [Abstract][Full Text] [Related]
15. Assessment of three human in vitro systems in the generation of major human excretory and circulating metabolites.
Dalvie D; Obach RS; Kang P; Prakash C; Loi CM; Hurst S; Nedderman A; Goulet L; Smith E; Bu HZ; Smith DA
Chem Res Toxicol; 2009 Feb; 22(2):357-68. PubMed ID: 19146377
[TBL] [Abstract][Full Text] [Related]
16. Predicting human hepatic clearance from in vitro drug metabolism and transport data: a scientific and pharmaceutical perspective for assessing drug-drug interactions.
Camenisch G; Umehara K
Biopharm Drug Dispos; 2012 May; 33(4):179-94. PubMed ID: 22407504
[TBL] [Abstract][Full Text] [Related]
17. Prediction of the hepatic and renal clearance of transporter substrates in rats using in vitro uptake experiments.
Watanabe T; Maeda K; Kondo T; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2009 Jul; 37(7):1471-9. PubMed ID: 19364828
[TBL] [Abstract][Full Text] [Related]
18. Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery.
Lüpfert C; Reichel A
Chem Biodivers; 2005 Nov; 2(11):1462-86. PubMed ID: 17191947
[TBL] [Abstract][Full Text] [Related]
19. Prediction of the intestinal first-pass metabolism of CYP3A and UGT substrates in humans from in vitro data.
Nishimuta H; Sato K; Yabuki M; Komuro S
Drug Metab Pharmacokinet; 2011; 26(6):592-601. PubMed ID: 21878741
[TBL] [Abstract][Full Text] [Related]
20. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
Gómez-Lechón MJ; Castell JV; Donato MT
Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]